Outcome and survival following primary and repeat surgery for World Health Organization Grade III meningiomas
- 1 August 2010
- journal article
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery
- Vol. 113 (2), 202-209
- https://doi.org/10.3171/2010.1.jns091114
Abstract
Object Despite an increased understanding of the biology of malignant meningioma tumor progression, there is a paucity of published clinical data on factors affecting outcomes following treatment for these lesions. The authors present the largest case series to date dealing with these tumors, providing analysis of 63 patients. Methods The authors identified all patients undergoing resection of WHO Grade III tumors at their institution over a 16-year period. They analyzed clinical data from these patients, and performed Kaplan-Meier and Cox regression analyses to determine the impact of different clinical characteristics and different treatment modalities on survival following initial and repeat surgery for these lesions. Results Sixty-three patients met inclusion criteria and were analyzed further. The median clinical follow-up time was 5 years (range 1–22 years). The 2-, 5-, and 10-year overall survival rates following initial operation were 82, 61, and 40%, respectively. Kaplan-Meier analysis demonstrat...This publication has 19 references indexed in Scilit:
- Adjuvant enoxaparin therapy may decrease the incidence of postoperative thrombotic events though does not increase the incidence of postoperative intracranial hemorrhage in patients with meningiomasJournal of Neuro-Oncology, 2009
- LONG-TERM RECURRENCE RATES OF ATYPICAL MENINGIOMAS AFTER GROSS TOTAL RESECTION WITH OR WITHOUT POSTOPERATIVE ADJUVANT RADIATIONNeurosurgery, 2009
- Notch Activation Is Associated with Tetraploidy and Enhanced Chromosomal Instability in MeningiomasNeoplasia, 2008
- RESEARCH ARTICLE: An Orthotopic Skull Base Model of Malignant MeningiomaBrain Pathology, 2008
- Molecular signatures define two main classes of meningiomasMolecular Cancer, 2007
- Recurrent meningiomaNeurology, 2007
- Irinotecan: a potential new chemotherapeutic agent for atypical or malignant meningiomasJournal of Neurosurgery, 2007
- Salvage chemotherapy With CPT-11 for recurrent meningiomaJournal of Neuro-Oncology, 2006
- Delayed Surgical Resection Reduces Intraoperative Blood Loss for Embolized MeningiomasNeurosurgery, 2002
- Applied Logistic RegressionPublished by Wiley ,2000